Clinical trial
Safety and Efficacy of Buagafuran Capsules in the Treatment of Generalized Anxiety Disorder: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Fixed-dose Phase Ⅲ Clinical Trial
NCT06243640 is registered in ClinicalTrials.gov with Beijing Union Pharmaceutical Factory Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Buagafuran Capsules in the Treatment of Generalized Anxiety Disorder: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled, Positive-controlled, Fixed-dose Phase Ⅲ Clinical Trial
- Lead sponsor
- Beijing Union Pharmaceutical Factory Ltd
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- July 25, 2023
- Completion date
- June 30, 2027
- Enrollment
- 504 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.